Cite
HARVARD Citation
Nakabori, T. et al. (2022). Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection. JGH open. 6 (5), pp. 309-316. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nakabori, T. et al. (2022). Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection. JGH open. 6 (5), pp. 309-316. [Online].